Bismarck Brief

Bismarck Brief

Share this post

Bismarck Brief
Bismarck Brief
AstraZeneca Shows Why Pharmaceutical Companies Don’t Innovate
Copy link
Facebook
Email
Notes
More

AstraZeneca Shows Why Pharmaceutical Companies Don’t Innovate

The British-Swedish pharmaceutical giant has made a financial and prestige comeback since its low point a decade ago. But it has done so without producing breakthroughs in scientific knowledge.

Samo Burja's avatar
Samo Burja
Jan 31, 2024
∙ Paid
14

Share this post

Bismarck Brief
Bismarck Brief
AstraZeneca Shows Why Pharmaceutical Companies Don’t Innovate
Copy link
Facebook
Email
Notes
More
1
Share
AstraZeneca CEO Pascal Soriot in 2023. Screenshot from YouTube. Source.

With a market capitalization of $210 billion as of January 2024, AstraZeneca is the most valuable company in the United Kingdom and one of the largest pharmaceutical companies in the world.1 Alongside Pfizer, Moderna, and Johnson & Johnson—all U.S. corporations—AstraZeneca was one of the few pharmaceutical companies that succeeded in rapidly developing and distributing a vaccine for COVID-19 during the pandemic’s initial spread from 2020 to 2021. This was surprising given that, at the time, the company had next to no experience in vaccine development.2 After nearly a decade of stagnation and decline, AstraZeneca’s total revenue doubled from 2018 to 2022, going from just over $20 billion to nearly $45 billion.3 The turnaround in this established corporation’s fortunes is the result of French CEO Pascal Soriot, who was installed in 2012 with the support of the Swedish Wallenberg family, one of the largest and oldest shareholders in the company. But AstraZeneca is a case study in why even a financially successful and well-run pharmaceutical company does not drive forward progress in science.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Samo Burja
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More